Diabetes is a chronic condition affecting over two million people in England and Wales. It is caused by an inability to use or produce the hormone insulin and leads to a rise in blood glucose. The National Diabetes Audit is considered to be the largest annual clinical audit in the world, providing an infrastructure for the collation, analysis, benchmarking and feedback of local data across the NHS.
The National Diabetes Audit measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. It collects and analyses data for use by a range of stakeholders to drive changes and improvements in the quality of services and health outcomes for people with diabetes.
The audit aims to improve outcomes for adults with diabetes receiving care from primary, secondary and community care providers. It consists of a suite of audits:
- Core diabetes audit (audits the care processes and outcomes of all diabetics treated in primary care and secondary care)
- Diabetes in pregnancy audit (NPID)
- National diabetes foot care audit (NDFA)
- National diabetes inpatient audit (NaDIA)
- Transition audit (a joint enterprise with the National Paediatric Diabetes Audit)
Additional information on all HQIP-commissioned projects including inclusion and exclusion criteria, data collection periods, and reporting dates, is available on the National Clinical Audit and Enquiries Directory. For further information about this project, please contact the project team directly using the contact details listed in the ‘Supplier Info’ section above.
Data collected on behalf of HQIP by all NCAPOP projects is routinely reported and these reports are available in the ‘Latest resources’ section. The reported data is also placed on the data.gov.uk website.
For details of how to apply for data that is not in the public domain, please see HQIP’s data access webpages.
Details of the contracts that HQIP awards are available at: www.gov.uk/contracts-finder.